Similarly, in a murine lymphoma model, a reduction in FDG uptake 16 h after initiation of etoposide treatment was explained by a decrease in the plasma membrane presentation of GLUT-1 and GLUT-3 [23]. The gene discussed is SLC2A1; the disease is lymphoma.